Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

14,467 total articles

Morgan Stanley Identifies Three Greater China Semiconductor Names Poised to Benefit from AI and Advanced Testing

Morgan Stanley Identifies Three Greater China Semiconductor Names Poised to Benefit from AI and Advanced Testing

Morgan Stanley has named three Greater China semiconductor-related companies it views as leading opportunities amid artificial intelligence-driven demand and rising adoption of advanced testing technologies. Using residual income models and specified cost-of-equity and growth assumptions, the bank set price targets for Winway Technology, MPI Corpor…

RHI Magnesita Posts Solid Q1 Results as Cost Measures Support Earnings

RHI Magnesita Posts Solid Q1 Results as Cost Measures Support Earnings

RHI Magnesita reported a 15% year-on-year increase in adjusted EBITA for Q1 2026, driven by cost discipline and self-help initiatives, with a 46% rise on a constant currency basis. While steel volumes were broadly flat and some regional markets softened, the Americas delivered a strong contribution. Management reiterated full-year fiscal 2026 EBITA…

Vimian Group Posts Q1 Revenue of 116 Million Euros, Surpasses Estimates

Vimian Group Posts Q1 Revenue of 116 Million Euros, Surpasses Estimates

Vimian Group AB reported first-quarter revenue of 116 million euros, an 8% year-over-year increase and 9% organic growth, beating consensus by 2%. Adjusted EBITA rose to 29.2 million euros, 3% above the prior year and 4% ahead of analyst expectations. Segment results were led by Diagnostics and Specialty Pharma, while MedTech and Veterinary Service…

Fuchs posts Q1 results above forecasts, raises sales outlook for 2026

Fuchs posts Q1 results above forecasts, raises sales outlook for 2026

Fuchs SE reported first-quarter sales of €934 million and EBIT of €125 million, both ahead of analyst estimates. The company delivered organic growth across regions, expanded EBIT margins in EMEA and Asia-Pacific, and improved free cash flow and net liquidity. Management raised its full-year sales target to above €3.7 billion while keeping EBIT gui…

Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk

Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk

Huhtamaki reported first quarter results that outperformed analyst estimates on both operating profit and earnings per share, with strength coming from its fiber unit and North American operations. Sales rose 1% versus prior quarter declines, aided in part by Easter timing. Management reiterated a steady 2026 trading outlook but cautioned that high…

Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit

Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit

Kambi Group reported modest revenue growth and a sizeable jump in EBITA margin for the first quarter, and reiterated its full-year EBITA guidance for fiscal 2026 even as a €4 million tax increase in Colombia creates a headwind. The supplier expects flat total expenses for the year as efficiency programmes offset inflation and flagged customer migra…

Pernod Ricard Calls Off Merger Negotiations With Brown-Forman

Pernod Ricard Calls Off Merger Negotiations With Brown-Forman

Pernod Ricard said it has ended merger discussions with Brown-Forman after the parties were unable to agree on mutually acceptable terms. Conversations that began a little over a month ago concluded without a deal. Pernod Ricard said the proposed combination - initially described as a partnership that would operate as a merger of equals when first …

Symrise Q1 Sales Top Estimates; Company Sticks to Full-Year Targets

Symrise Q1 Sales Top Estimates; Company Sticks to Full-Year Targets

Symrise reported first-quarter revenue of €1,249 million, beating analyst expectations of €1,231 million. Organic sales contracted 0.4% versus a consensus forecast of -1.6%. The Taste, Nutrition & Health division showed organic growth of 1.7%, while Scent & Care fell 3.4% organically. The company left its fiscal 2026 guidance for organic growth and…

Melexis Posts Q1 Revenue Above Estimates, Keeps H1 Targets Intact

Melexis Posts Q1 Revenue Above Estimates, Keeps H1 Targets Intact

Melexis NV reported first-quarter sales that modestly exceeded analyst expectations while keeping its guidance for the first half of 2026 unchanged. The company delivered slightly stronger-than-expected revenue and margins, but earnings per share fell short of consensus. Management signaled stabilization in China automotive demand, solid European m…